Catalyst Wire Dossier Catalyst Wire Dossier

Low molecular weight iron dextran (intravenous)

iron dextran, low molecular weight
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Low molecular weight iron dextran (intravenous), covering 2018-06-28 to 2018-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women [Phase 2]

See pricing